New release of CAAS IntraVascular for analysis of IVUS, NIRS-IVUS and OCT datasets

Published on:
Pie Medical Imaging announces the release of CAAS IntraVascular 2.0, the dedicated software for analysis of IVUS, NIRS-IVUS and OCT datasets. This new release contains an optimized OCT analysis and the in depth analysis of NIRS-IVUS datasets.  Import your data easily from the console or PACS into the study list which provides a clear overview of your data. CAAS IntraVascular is used by the major corelabs and academic hospitals around the world and has 510(k) clearance for both IVUS and OCT. CAAS IntraVascular - OCT analysisThe raw data import supports files of both OCT (St. Jude Medical Inc.) and OFDI (Terumo) format. Z-offset correction enables to adjust the calibration, even after the export from the console. Analyze your data fast and easy with automatic lumen contour detection, EEM segmentation and stent strut analysis. The position of the struts is clearly visualized and automatically classified into covered, uncovered and malapposed struts. Also a 3D visualization of the vessel and stent struts is provided. In-depth ChemogramTM AnalysisBesides the current IVUS and (NIRS)-IVUS functionality of lumen, contour and stent contour detection, CAAS IntraVascular 2.0 contains the most extensive in-depth ChemogramTM analysis module. This module provides visualization and dedicated analysis of your NIRS-IVUS data such as custom LCBI measurements. ResultsCAAS IntraVascular 2.0 contains on the fly-reporting and results can also be exported easily in a XML file (MS Excel compatible). Experience the software now in a 2 week free trial. About Pie Medical Imaging BVPie Medical Imaging BV has more than 30 years of experience in cardiovascular analysis software and is well known for its CAAS and 3mensio product lines. Pie Medical Imaging, develops and markets software for diagnosis and planning of treatment, guidance and quantitative analysis of cardiovascular images. The company is based in Maastricht and is part of the Esaote group. Esaote S.p.A. is a worldwide provider of Ultrasound and dedicated MRI. More information is available at: www.piemedicalimaging.com. 

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
FDA clears AI screening tool for cardiac amyloidosis
IVUS-guided PCI reduces risks in patients with diabetes
SCCT leaders unpack the 2025 Medicare payment increase for coronary CTA
Global shortage of nuclear imaging isotopes may be over
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."